N-[4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]-3-pyridinecarboxamide

ID: ALA4533277

Cas Number: 420090-03-5

PubChem CID: 1358652

Max Phase: Preclinical

Molecular Formula: C15H9Cl2N3OS

Molecular Weight: 350.23

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  O=C(Nc1nc(-c2ccc(Cl)c(Cl)c2)cs1)c1cccnc1

Standard InChI:  InChI=1S/C15H9Cl2N3OS/c16-11-4-3-9(6-12(11)17)13-8-22-15(19-13)20-14(21)10-2-1-5-18-7-10/h1-8H,(H,19,20,21)

Standard InChI Key:  WGXGEUQSJHCURN-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 22 24  0  0  0  0  0  0  0  0999 V2000
   21.0406  -12.9595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8578  -12.9595    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   22.1121  -12.1828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4492  -11.7007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7904  -12.1828    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.5594  -13.6200    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.4480  -10.8836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1567  -10.4746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1558   -9.6581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4469   -9.2498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7375   -9.6639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7419  -10.4789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4446   -8.4326    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   22.8631   -9.2488    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   19.7468  -13.5336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2656  -14.1941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4154  -12.7866    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.4527  -14.1051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9717  -14.7648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3030  -15.5127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1201  -15.5970    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.5975  -14.9364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  1  2  0
  1  6  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  4  7  1  0
 10 13  1  0
  9 14  1  0
  6 15  1  0
 15 16  1  0
 15 17  2  0
 16 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 16  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4533277

   N-[4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]pyridine-3-carboxamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 350.23

Molecular Weight (Monoisotopic): 348.9843

AlogP: 4.76

#Rotatable Bonds: 3

Polar Surface Area: 54.88

Molecular Species: NEUTRAL

HBA: 4

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 4

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 10.93

CX Basic pKa: 3.49

CX LogP: 4.43

CX LogD: 4.43

Aromatic Rings: 3

Heavy Atoms: 22

QED Weighted: 0.74

Np Likeness Score: -2.35

References

1. Simpson GL, Bertrand SM, Borthwick JA, Campobasso N, Chabanet J, Chen S, Coggins J, Cottom J, Christensen SB, Dawson HC, Evans HL, Hobbs AN, Hong X, Mangatt B, Munoz-Muriedas J, Oliff A, Qin D, Scott-Stevens P, Ward P, Washio Y, Yang J, Young RJ..  (2019)  Identification and Optimization of Novel Small c-Abl Kinase Activators Using Fragment and HTS Methodologies.,  62  (4): [PMID:30689376] [10.1021/acs.jmedchem.8b01872]

Source

Source(1):

• Scientific Literature